Chinese herbal medicine for lung cancer — A critical literature review (continued)

H. L. M. Liang; C. C. L. Xue; D. H. Zhou; C. G. Li

doi:10.1007/BF02838045

Your Location：

Home >

Browse articles >

Chinese herbal medicine for lung cancer — A critical literature review (continued)

ReviewPaper | Updated：2021-08-27

- Chinese herbal medicine for lung cancer — A critical literature review (continued)
- Chinese herbal medicine for lung cancer — A critical literature review (continued)
- 中国结合医学杂志（英文版） 2003年9卷第3期页码：232-236
- Affiliations：
  
  1. The RMIT Chinese Medicine Research Group, RMIT University, Bundoora,Australia
  2. Institute of Oncology, Guangzhou University of Traditional Chinese Medicine,Guangzhou,China
- Author bio：
- Funds：
- DOI：10.1007/BF02838045
  中图分类号：
- 纸质出版日期：2003，
Scan for full text
Liang, H.L.M., Xue, C.C.L., Zhou, D.H. et al. Chinese herbal medicine for lung cancer — A critical literature review (continued)., Chin. J. Integr. Med. 9, 232–236 (2003). https://doi.org/10.1007/BF02838045

H. L. M. Liang, C. C. L. Xue, D. H. Zhou, et al. Chinese herbal medicine for lung cancer — A critical literature review (continued)[J]. Chinese Journal of Integrative Medicine, 2003,9(3):232-236.
Liang, H.L.M., Xue, C.C.L., Zhou, D.H. et al. Chinese herbal medicine for lung cancer — A critical literature review (continued)., Chin. J. Integr. Med. 9, 232–236 (2003). https://doi.org/10.1007/BF02838045 DOI：

H. L. M. Liang, C. C. L. Xue, D. H. Zhou, et al. Chinese herbal medicine for lung cancer — A critical literature review (continued)[J]. Chinese Journal of Integrative Medicine, 2003,9(3):232-236. DOI： 10.1007/BF02838045.

摘要

In conclusion

from the evidence gathered

it may be appropriate to suggest that CHMs may have efficacy for the treatment of patients with LC

and combination of CHMs with chemotherapy or radiotherapy may be additive or synergistic in controlling LC. In addition

CHMs may reduce some adverse effects associated with chemotherapy or radiotherapy. Moreover

CHMs may be beneficial for improving quality of life and prolonging survival time of patients with LC. However

we are cautious because of methodological flaws in the majority of the clinical studies reviewed. It is difficult to draw conclusions with regard to efficacy of CHMs. The mechanisms of actions of CHMs for LC largely remain unknown. Thus

more rigorous studies that address weaknesses identified are required for further evaluation of efficacy and safety of different Chinese herbs and formulae in the management of LC.

Abstract

In conclusion

from the evidence gathered

it may be appropriate to suggest that CHMs may have efficacy for the treatment of patients with LC

and combination of CHMs with chemotherapy or radiotherapy may be additive or synergistic in controlling LC. In addition

CHMs may reduce some adverse effects associated with chemotherapy or radiotherapy. Moreover

CHMs may be beneficial for improving quality of life and prolonging survival time of patients with LC. However

more rigorous studies that address weaknesses identified are required for further evaluation of efficacy and safety of different Chinese herbs and formulae in the management of LC.

关键词

Chinese Herbal MedicineBlood StasisSpecific FormulaHerbal FormulaRadix Astragalus

Keywords

Chinese Herbal MedicineBlood StasisSpecific FormulaHerbal FormulaRadix Astragalus

references

LIU JX, SHI ZM, XU ZH, et al. Clinical study on advanced primary lung adenocarcinoma treated with therapeutic method of nourishing Yin, generating Jin, Benefiting Qi and warming Yang. J Tradit Chin Med 1995; 36 (3): 155–158.

LIU JX, XU ZH, SHI ZM, et al. Method of supporting the Healthy Qi for advanced primary non-small cell lung cancer: a prospective study of 122 cases. Acta Med Sin 1987; 2(1): 11–16.

XIA LM, LIN QQ, CHENG FX, et al. Clinical effect analysis of Chinese herbal medicine for primary lung cancer. Chin J Basic Med TCM 2001; 7(8): 52–53.

LIU JX, PAN MQ, LI YH, et al. Jinfukang oral liquid for treatment of primary non-small cell lung cancer. Tumour 2001; 21(6): 463–65.

PAN MQ, LI YH, LIU JX, et al. Feifu Decoction for primary squamous lung carcinoma in comparison of chemotherapy: study of 80 cases. Acta Med Sin 1990; 5 (3): 19–21.

PU BG, TANG WX, CHANG ZQ, et al. Clinical observation on treatment of advanced primary lung cancer with Feiliuping Extract. J Tradit Chin Med 1991; (4): 21–23.

XU JP, HUANG JJ, YANG F, et al. Fufei Decoction for middle and late stages of lung cancer. Acta Med Sin 1990; 5(2) 37–39.

LI PW, ZHANG DZ, HAO YX, et al. Pingfei Granules for non-small cell lung cancer: clinical study of 109 cases. J Tradit Chin Med 1995 36(2): 87–88.

SUN DX, QIU WY, ZHAO SZ. Feikang decoction for treatment of middle and later stages of non-small cell lung cancer. ACMP 2002; 30(2): 49–50.

XIONG MN, ZENG JQ. Clinical trial on treatment of lung cancer with integrated traditional Chinese and western medicine. Cancer Res Prev Treat 1998; 25(3): 214 -215.

FENG YZ. Clinical observation on treatment of advanced lung cancer by Fuzhengyiliu Decoction combined with chemotherapy. Cancer Res Prev Treat 1998; 25(3): 211 -213.

MA LY. Yifei Capsule for primary lung cancer. J Shandong Univ Tradit Chin Med 1998; 22(1): 50–55.

HAO YB, CAI MM, ZHU XD. The therapeutic method of Shen reinforcing for treatment of advanced lung cancer: study of 76 cases. J Nanjing Univ of TCM 1993; 9 (2): 55–56.

YANG QJ, LEI LW, PAN XX, et al. Clinical and experimental studies on medicinal liquid No. 892 in treating lung cancer. Chin Surgery J Integr Tradit West Med 1998; 4(2): 68–70.

LIU X, WANG B, FU X. Clinical study on treatment of advanced non-small cell lung cancer with Chinese herbal medicine combined with synchronous radio- and chemotherapy. Chin J Integr Tradit West Med 2000; 20 (6): 427–429.

CAI HB, DAI FG, MIN QF, et al. Clinical study of the effects of radiotherapy in combination with traditional Chinese medicine on non-small cell lung cancer. J First Milit Med Univ 2002; 22(12): 1112–1113.

Zhang DZ, Xu JD, Li PW, et al. Clinical and experimental studies on improving radiation sensibility for lung cancer with Fuzheng Zengxiao formula. China Surgery J Integr Tradit West Med 1998; 4(2): 71–75.

CHEN SL, ZANG ZF, MENG SH et al. Pingxiao Tablet combined with radiotherapy for the middle and late stages of lung cancer: study of 62 cases. Henan J Oncol 1995; 8(3): 270–271.

GUO XZ. Dictionary of poisonous Chinese herbal medicine. Tianjin: Tianjin Publishing House of Science and Technology, 1992: 91–94, 195–198, 192–197, 225–228, 265–268, 382–385, 414–417, 635–639.

The Pharmacopoeia Commission of China (PCC). Pharmacopoeia of PR China (Vol. 1 in English). 1997 ed. Beijing: Chemical Industry Press, 1997.

FULL TEXT LINK

More>

浏览量

347

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy

To explore the chinese medicine syndrome types and integrative therapy from clinical relative factors of patients with advanced prostate cancer

Thirty-One patients of postoperational relapsed endometriosis treated with integrated traditional Chinese and Western medicine

Development is a high level inheritance for China Time-honored Brand products

Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren’s syndrome